CN110143975B - Fluorescent-labeled O of naphthalimide or perylene bisimide6-benzylguanine derivatives and process for the preparation thereof - Google Patents

Fluorescent-labeled O of naphthalimide or perylene bisimide6-benzylguanine derivatives and process for the preparation thereof Download PDF

Info

Publication number
CN110143975B
CN110143975B CN201910416208.4A CN201910416208A CN110143975B CN 110143975 B CN110143975 B CN 110143975B CN 201910416208 A CN201910416208 A CN 201910416208A CN 110143975 B CN110143975 B CN 110143975B
Authority
CN
China
Prior art keywords
structural formula
compound
naphthalimide
molar ratio
benzylguanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910416208.4A
Other languages
Chinese (zh)
Other versions
CN110143975A (en
Inventor
周祎迪
沈卫平
于静
宋力平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Shanghai for Science and Technology
Original Assignee
University of Shanghai for Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Shanghai for Science and Technology filed Critical University of Shanghai for Science and Technology
Priority to CN201910416208.4A priority Critical patent/CN110143975B/en
Publication of CN110143975A publication Critical patent/CN110143975A/en
Application granted granted Critical
Publication of CN110143975B publication Critical patent/CN110143975B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention provides O of fluorescent labeling of naphthalimide or perylene bisimide6-benzylguanine derivatives and processes for their preparation. The derivative of the invention is chemically modified by taurine, and the naphthalimide and the perylene bisimide with excellent water solubility are used for preparing O with high fluorescence yield and good water solubility6Benzyl guanine derivatives for improving the Tag-specific substrate O in the SNAP-Tag protein labeling technique6The problem of poor water solubility of Benzylguanine derivatives (BG) and insufficient interference of nonspecific staining background by washing with water. The invention uses taurine to react with the naphthalic anhydride and the perylene anhydride to obtain the sulfonic acid salt of the naphthalimide and the perylene imide, and the product has good water solubility.

Description

萘酰亚胺或苝酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物及其制 备方法Naphthalimide or peryleneimide fluorescently labeled O6-benzylguanine derivatives and preparation method thereof

技术领域technical field

本发明属于蛋白质标记物的合成,涉及萘酰亚胺或苝酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物及其制备方法。The invention belongs to the synthesis of protein markers, and relates to O 6 -benzylguanine derivatives labeled with naphthalimide or peryleneimide fluorescence and a preparation method thereof.

背景技术Background technique

蛋白质特异性的小分子荧光染料标记技术克服了荧光蛋白(fluorescentprotein FP)在蛋白质研究领域的诸多局限性。该类技术通过标准的基因工程手段构建蛋白质与多肽,蛋白质标签的重组蛋白,利用荧光探针配体与相应多肽、蛋白质标签的特异性高效识别,实现对靶蛋白的定点荧光标记。SNAP-Tag凭借对靶蛋白所具有的高特异性和稳定性,以及配体功能多样性等独特优势,从众多靶向标记技术中脱颖而出。成为了最优秀的融合标签之一,并在众多领域得到了广泛应用。比如,活体成像、细胞成像、蛋白质体外研究、蛋白质体内研究、微生物致病机理研究、疾病诊断等。Protein-specific small molecule fluorescent dye labeling technology overcomes many limitations of fluorescent protein (fluorescentprotein FP) in the field of protein research. This type of technology uses standard genetic engineering methods to construct proteins and polypeptides, and recombinant proteins with protein tags, and uses fluorescent probe ligands to specifically and efficiently identify corresponding peptides and protein tags to achieve site-specific fluorescent labeling of target proteins. SNAP-Tag stands out from many targeted labeling technologies due to its unique advantages such as high specificity and stability to target proteins, as well as functional diversity of ligands. It has become one of the best fusion labels and has been widely used in many fields. For example, in vivo imaging, cell imaging, protein in vitro research, protein in vivo research, microbial pathogenic mechanism research, disease diagnosis, etc.

SNAP-Tag是由johnsson等于2003年开发的,它是通过改造人的O6-鸟嘌呤-DNA烷基转移酶(human O6-alkylguanine-DNA alkyitransferase,hAGC)获得的一种特异性蛋白质标签。hAGT 是一种由207种氨基酸组成的单体蛋白,它可以将甲基化DNA鸟嘌呤O6位置的的甲基转移到自身的hAGT有活性的半胱氨酸巯基(Cys145)上,从而实现对DNA的修复。针对hAGT结构的改造一方面降低原有蛋白结构于甲基化DNA的相互作用,另一方面提高其与O6修饰的苄基鸟嘌呤(benzyiguanine,BG)的特异性反应活性。位于SNAP-Tag活性位点的半胱氨酸巯基 (Cys145)可以与BG的苄基发生反应,在蛋白与底物之间形成非常稳定的共价键实现标记,其过程如下所示:SNAP-Tag was developed by johnsson et al. in 2003. It is a specific protein tag obtained by modifying human O 6 -alkylguanine -DNA alkyitransferase (hAGC). hAGT is a monomeric protein composed of 207 amino acids, which can transfer the methyl group at the O 6 position of methylated DNA guanine to its own hAGT-active cysteine thiol (Cys145), thereby achieving Repair of DNA. The modification of hAGT structure reduces the interaction between the original protein structure and methylated DNA on the one hand, and improves its specific reactivity with O 6 modified benzyiguanine (BG) on the other hand. The cysteine sulfhydryl group (Cys145) located in the active site of SNAP-Tag can react with the benzyl group of BG to form a very stable covalent bond between the protein and the substrate to achieve labeling. The process is as follows:

Figure BDA0002064516160000011
Figure BDA0002064516160000011

SNAP-Tag独特的优点有:蛋白标签与底物反应速度快且特异性高;通过共价键结合的蛋白稳定性好,即使在体外分析SDS-PAGE的变性条件下仍可稳定标记;通过模块化的设计将标签特异性底物BG与功能染料结合,灵活性高;便于衍生多样化的荧光染料,通用性强,可满足各种荧光成像的需求。目前,SNAP-Tag在细胞内蛋白质标记、体外分析及靶向荧光探测的研究中获得了非常广泛的应用。不过这一方法也存在一定的不足;标签特异性底物BG的合成较复杂,且与染料结合后可能存在溶解分散性较差的问题;大多数染料在使用时,标记前后荧光信号无明显差异,需要充分洗涤去除非特异性染色,可能存在背景干扰。而本发明为改良 SNAP-Tag技术中的不足,提供了新型蛋白质特异性的分子荧光标记物。The unique advantages of SNAP-Tag are: the protein tag reacts with the substrate quickly and with high specificity; the protein bound by covalent bond has good stability, and can be stably labeled even under the denaturing conditions of SDS-PAGE in vitro analysis; The chemical design combines the label-specific substrate BG with functional dyes, with high flexibility; it is easy to derive a variety of fluorescent dyes, and has strong versatility, which can meet the needs of various fluorescence imaging. At present, SNAP-Tag has been widely used in the research of intracellular protein labeling, in vitro analysis and targeted fluorescence detection. However, this method also has certain shortcomings; the synthesis of the label-specific substrate BG is complicated, and there may be a problem of poor solubility and dispersion after being combined with the dye; when most dyes are used, there is no significant difference in the fluorescence signal before and after labeling. , requires extensive washing to remove non-specific staining, and there may be background interference. However, the present invention provides a novel protein-specific molecular fluorescent marker for improving the deficiencies in the SNAP-Tag technology.

发明内容SUMMARY OF THE INVENTION

本发明的一个目的是提供一种萘酰亚胺和苝酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物。An object of the present invention is to provide a fluorescently labeled O 6 -benzylguanine derivative of naphthalimide and peryleneimide.

本发明的目的之二在于提供该衍生物的制备方法。Another object of the present invention is to provide a preparation method of the derivative.

为达到上述目的ID,本发明采用如下反应机理:In order to achieve above-mentioned purpose ID, the present invention adopts following reaction mechanism:

Figure BDA0002064516160000021
Figure BDA0002064516160000021

Figure BDA0002064516160000031
Figure BDA0002064516160000031

Figure BDA0002064516160000041
Figure BDA0002064516160000041

Figure BDA0002064516160000051
Figure BDA0002064516160000051

根据上述反应机理,本发明采用如下技术方案:According to above-mentioned reaction mechanism, the present invention adopts following technical scheme:

一种萘酰亚胺或苝酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物,其特征在于该化合物的结构通式为下列之一:A naphthalimide or peryleneimide fluorescently labeled O 6 -benzylguanine derivative, characterized in that the general structural formula of the compound is one of the following:

a.a.

Figure BDA0002064516160000061
Figure BDA0002064516160000061

b.b.

Figure BDA0002064516160000062
Figure BDA0002064516160000062

c.c.

Figure BDA0002064516160000063
Figure BDA0002064516160000063

d.d.

Figure BDA0002064516160000064
Figure BDA0002064516160000064

其中R=烷基、环烷基、芳基、杂芳基或聚氧乙烯醚链。where R = alkyl, cycloalkyl, aryl, heteroaryl or polyoxyethylene ether chain.

一种根据权利要求1制备所述的萘酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物a的方法,其特征在于该方法的具体步骤为:A method for preparing the O6- benzylguanine derivative a of the fluorescently labeled naphthalimide according to claim 1, wherein the specific steps of the method are:

a.将6-氯鸟嘌呤和N-甲基吡咯烷按1:1.5-1:2.1的摩尔比溶于N,N-二甲基甲酰胺中, 60℃-100℃,反应24h-48h,反应结束抽滤,用丙酮洗涤滤渣,抽滤得到化合物M,其结构式为:a. Dissolve 6-chloroguanine and N-methylpyrrolidine in N,N-dimethylformamide at a molar ratio of 1:1.5-1:2.1, 60℃-100℃, react for 24h-48h, The reaction finishes suction filtration, and the filter residue is washed with acetone, and suction filtration obtains compound M, and its structural formula is:

Figure BDA0002064516160000071
Figure BDA0002064516160000071

b.将4-溴-1,8-萘酐和有机磺酸盐按1:1.2-1:1.5的摩尔比溶于无水乙醇中,回流条件下反应 6h-12h,冷却,滤出固体粗产物,再经分离提纯得到化合物Ⅰb,其结构式为:b. Dissolve 4-bromo-1,8-naphthalene anhydride and organic sulfonate in absolute ethanol at a molar ratio of 1:1.2-1:1.5, react under reflux conditions for 6h-12h, cool, and filter out the solid crude The product is separated and purified to obtain compound Ib, and its structural formula is:

Figure BDA0002064516160000072
所述的有机磺酸盐的结构式为:NH2RSO3H;
Figure BDA0002064516160000072
The structural formula of the organic sulfonate is: NH 2 RSO 3 H;

c.将步骤b所得中间产物Ⅰb、氨甲基苄醇和碳酸钾按1:1:1.2-1;1.5:2.0的摩尔比溶于N,N- 二甲基甲酰胺,回流反应6h~8h,得到深褐色反应液,调节pH为4~5,除去大部分溶剂,得到糊状物质,抽滤,得到粗产物;再经分离提纯得化合物Ⅰc,其结构式为:c. Dissolve the intermediate product Ib, aminomethylbenzyl alcohol and potassium carbonate obtained in step b in N,N-dimethylformamide in a molar ratio of 1:1:1.2-1; 1.5:2.0, and perform a reflux reaction for 6h~8h, A dark brown reaction solution was obtained, the pH was adjusted to 4-5, and most of the solvent was removed to obtain a paste-like substance, which was filtered with suction to obtain a crude product; and then separated and purified to obtain compound Ic, whose structural formula is:

Figure BDA0002064516160000073
Figure BDA0002064516160000073

d.将步骤c所得中间产物Ⅰc和步骤a中所得中间体M和t-BuOK按1:2:5-1:3:5的摩尔比溶于N,N-二甲基甲酰胺中,惰性气氛保护下,反应3h-8h,经分离提纯得到萘酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物a,其结构式为:d. The intermediate product Ic obtained in step c and the intermediate M and t-BuOK obtained in step a are dissolved in N,N-dimethylformamide in a molar ratio of 1:2:5-1:3:5, inert Under the protection of atmosphere, the reaction is carried out for 3h-8h, and the naphthalimide fluorescently labeled O 6 -benzylguanine derivative a is obtained by separation and purification, and its structural formula is:

Figure BDA0002064516160000081
Figure BDA0002064516160000081

一种制备根据权利要求1所述的萘酰亚胺荧光标记的O6-苄基鸟嘌呤同分子孪生的荧光蛋白质标记物c的方法,特征在于该方法的具体步骤为:A method for preparing the fluorescent protein marker c of naphthalimide fluorescently labeled O 6 -benzylguanine homomolecular twins according to claim 1, characterized in that the specific steps of the method are:

e.将4-溴-1,8-萘酐和氨甲基苄醇按1:1.2-1:1.5的摩尔比溶于无水乙醇中,回流条件下反应 6h-12h,冷却,滤出固体粗产物,再经分离提纯得到化合物Ⅲa,其结构式为:e. Dissolve 4-bromo-1,8-naphthalene anhydride and aminomethylbenzyl alcohol in absolute ethanol at a molar ratio of 1:1.2-1:1.5, react under reflux conditions for 6h-12h, cool, and filter out the solid The crude product is separated and purified to obtain compound IIIa, whose structural formula is:

Figure BDA0002064516160000082
Figure BDA0002064516160000082

f.将步骤e所得中间产物Ⅲa、氨甲基苄醇和碳酸钾按1:1:1.2-1;1.5:2.0的摩尔比溶于 N,N-二甲基甲酰胺,回流反应6h~8h,得到深褐色反应液,调节pH为4~5,除去大部分溶剂,得到糊状物质,抽滤,得到粗产物;再经分离提纯得化合物Ⅲb,其结构式为:f. The intermediate product IIIa, aminomethylbenzyl alcohol and potassium carbonate obtained in step e were dissolved in N,N-dimethylformamide in a molar ratio of 1:1:1.2-1; 1.5:2.0, and the reflux reaction was carried out for 6h~8h, A dark brown reaction solution was obtained, the pH was adjusted to 4-5, and most of the solvent was removed to obtain a paste-like substance, which was filtered with suction to obtain a crude product; and then separated and purified to obtain compound IIIb, whose structural formula is:

Figure BDA0002064516160000083
Figure BDA0002064516160000083

g.将步骤f所得产物Ⅲb、步骤a所得产物M、t-BuOK按1:2:5-1:3:5的摩尔比溶于N,N-二甲基甲酰胺中,惰性气氛保护下,反应3h-8h,分离得到萘酰亚胺荧光标记的O6-苄基鸟嘌呤同分子孪生的荧光蛋白质标记物c,其结构式为:g. Dissolve the product IIIb obtained in step f, product M obtained in step a, and t-BuOK in N,N-dimethylformamide in a molar ratio of 1:2:5-1:3:5, under the protection of an inert atmosphere , react for 3h-8h, and separate and obtain the fluorescent protein marker c of O 6 -benzylguanine homomolecular twinned with naphthalimide fluorescently labeled, and its structural formula is:

Figure BDA0002064516160000084
Figure BDA0002064516160000084

一种制备根据权利要求1所述的苝酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物的方法,其特征在于该方法的具体步骤为:A method for preparing the peryleneimide fluorescently labeled O 6 -benzylguanine derivative according to claim 1, wherein the specific steps of the method are:

a.将四氯苝酐和有机磺酸盐按1:1.2-1:1.5的摩尔比溶于乙二醇甲醚中,100℃-120℃反应a. Dissolve tetrachloroperylene anhydride and organic sulfonate in ethylene glycol methyl ether in a molar ratio of 1:1.2-1:1.5, and react at 100℃-120℃

6h-12h,经分离提纯得到化合物Ⅱa,其结构式为:6h-12h, through separation and purification, compound IIa is obtained, and its structural formula is:

Figure BDA0002064516160000091
Figure BDA0002064516160000091

所述的四氯苝酐的结构式为:The structural formula of described tetrachloroperylene anhydride is:

Figure BDA0002064516160000092
Figure BDA0002064516160000092

所述的有机磺酸盐的结构式为:NH2RSO3H;The structural formula of the organic sulfonate is: NH 2 RSO 3 H;

b.将步骤a所得中间产物Ⅱa和氨甲基苄醇按照1:1.2-1:1.5的摩尔比溶于无水乙醇中,回流条件下搅拌反应6h-12h,除去溶剂,所得粗产物经分离提纯得到固体化合物Ⅱb,其结构式为:b. Dissolve the intermediate product IIa and aminomethylbenzyl alcohol obtained in step a in absolute ethanol according to the molar ratio of 1:1.2-1:1.5, stir and react under reflux conditions for 6h-12h, remove the solvent, and separate the obtained crude product Purification to obtain solid compound IIb, its structural formula is:

Figure BDA0002064516160000101
Figure BDA0002064516160000101

c.将步骤b所得中间产物Ⅱb和对叔丁基酚和碳酸钾按1:4:4-1:5:6的摩尔比溶于N,N-二甲基甲酰胺,回流条件下搅拌反应6~8小时,所得粗产品经分离提纯得到化合物Ⅱc,其结构式为:c. The intermediate product IIb obtained in step b, p-tert-butylphenol and potassium carbonate are dissolved in N,N-dimethylformamide in a molar ratio of 1:4:4-1:5:6, and the reaction is stirred under reflux conditions After 6 to 8 hours, the obtained crude product is separated and purified to obtain compound IIc, and its structural formula is:

Figure BDA0002064516160000102
Figure BDA0002064516160000102

d.将步骤c所得产物Ⅱc、权利要求2步骤a中产物M和t-BuOK按1:1.2:3-1:2.1:5的摩尔比,惰性气氛保护下,反应3h-5h,经分离提纯得到苝酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物b,其结构式为:d. The product IIc obtained in step c, product M and t-BuOK in claim 2, step a, are reacted for 3h-5h in a molar ratio of 1:1.2:3-1:2.1:5 under the protection of an inert atmosphere, and are separated and purified The O 6 -benzylguanine derivative b, which is fluorescently labeled with peryleneimide, is obtained, and its structural formula is:

Figure BDA0002064516160000111
Figure BDA0002064516160000111

一种制备根据权利要求1制备所述苝酰亚胺荧光标记的O6-苄基鸟嘌呤同分子荧光孪生标记物的制备方法,其特征在于该方法的具体步骤是:A preparation method for preparing the fluorescently labeled O 6 -benzylguanine homomolecular fluorescent twinned label of the peryleneimide according to claim 1, characterized in that the specific steps of the method are:

e.将四氯苝酐和氨甲基苄醇按1:2-1:3的摩尔比溶于乙二醇甲醚中,100℃-140℃反应6h-12h,经分离提纯得到化合物Ⅳa,其结构式为:e. Dissolve tetrachloroperylene anhydride and aminomethylbenzyl alcohol in ethylene glycol methyl ether at a molar ratio of 1:2-1:3, react at 100°C-140°C for 6h-12h, and obtain compound IVa through separation and purification, Its structural formula is:

Figure BDA0002064516160000112
Figure BDA0002064516160000112

f.将步骤e所得产物Ⅳa和对叔丁基酚和碳酸钾按1:4:5-1:5:5的摩尔比溶于N,N-二甲基甲酰胺,回流条件下搅拌反应6~8小时,然后蒸除溶剂,所得粗产品经分离提纯得到化合物Ⅳb,其结构式为:f. product IVa obtained in step e, p-tert-butylphenol and potassium carbonate are dissolved in N,N-dimethylformamide in a molar ratio of 1:4:5-1:5:5, and the reaction is stirred under reflux conditions for 6 ~8 hours, then the solvent is evaporated, and the obtained crude product is separated and purified to obtain compound IVb, and its structural formula is:

Figure BDA0002064516160000121
Figure BDA0002064516160000121

g.将步骤f所得产物Ⅳb和权利要求2步骤a中产物M和t-BuOK按1:2:5-1:2.5:5的摩尔比,惰性气氛保护下,反应3h-5h,经分离提纯得到苝酰亚胺荧光标记的O6-苄基鸟嘌呤同分子荧光孪生标记物d,其结构式为:g. product M and t-BuOK obtained in step f and product M and t-BuOK in step a of claim 2 are in a molar ratio of 1:2:5-1:2.5:5, under the protection of an inert atmosphere, react for 3h-5h, and are separated and purified The peryleneimide fluorescently labeled O 6 -benzylguanine homomolecular fluorescent twin label d is obtained, and its structural formula is:

Figure BDA0002064516160000122
Figure BDA0002064516160000122

本发明的牛磺酸化学修饰的具有优良水溶性的的萘酰亚胺和苝酰亚胺,制备高荧光产率和良好水溶性的O6-苄基鸟嘌呤衍生物,以改进SNAP-Tag蛋白质标记技术中,标签特异性底物O6-苄基鸟嘌呤衍生物(Benzylguanine,BG)的水溶性较差和水洗除去非特异性染色背景干扰不足的问题。本发明用牛磺酸与萘酐和苝酐反应,获得萘酰亚胺和苝酰亚胺的磺酸盐,产物呈现良好的水溶性,进一步用氨甲基苄醇进行反应,然后与鸟嘌呤活性中间体偶联,获得目标产物。同时合成目标分子的二聚体(利用同分子孪生协同效应),可望提高该类特异性标记蛋白的靶向性能。The taurine chemically modified naphthalene imide and perylene imide of the present invention have excellent water solubility, and prepare O 6 -benzylguanine derivatives with high fluorescence yield and good water solubility, so as to improve SNAP-Tag In protein labeling technology, the label-specific substrate O 6 -benzylguanine derivative (Benzylguanine, BG) has poor water solubility and insufficient washing to remove non-specific staining background interference. In the present invention, taurine is reacted with naphthalene anhydride and perylene anhydride to obtain sulfonates of naphthalene imide and perylene imide, and the product has good water solubility, further reacts with aminomethylbenzyl alcohol, and then reacts with guanine The reactive intermediates are coupled to obtain the target product. Simultaneously synthesizing dimers of target molecules (using the synergistic effect of homomolecular twinning) is expected to improve the targeting performance of such specific labeled proteins.

附图说明Description of drawings

图1是实施例一中萘酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物A1的归一化荧光激发发射光谱;Fig. 1 is the normalized fluorescence excitation emission spectrum of O 6 -benzylguanine derivative A 1 fluorescently labeled with naphthalimide in Example 1;

图2是实施例2中苝酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物c的归一化荧光激发发射光谱。FIG. 2 is the normalized fluorescence excitation emission spectrum of the peryleneimide fluorescently labeled O 6 -benzylguanine derivative c in Example 2. FIG.

具体实施方式Detailed ways

本发明结合实施例做进一步说明,但本发明不受下述实施例的限定。The present invention is further described with reference to the examples, but the present invention is not limited by the following examples.

实施例一:萘酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物A1的制备Example 1: Preparation of Naphthalimide Fluorescently Labeled O 6 -benzylguanine Derivative A 1

a.在250mL圆底烧瓶中加入6-氯鸟嘌呤1.69g(10mmol),80mL N,N-二甲基甲酰胺作溶剂, 加入N-甲基吡咯1.75g(21mmol),60℃搅拌24小时。反应完成后,冷却,沉淀物用20mL 丙酮洗涤,然后过滤纯化,得到白色固体1.94g,产率为76.5%。1H NMR(500MHz,DMSO-d6, ppm):δ13.41(s,1H),8.35(s,1H),7.12(s,2H),4.67–4.48(m,2H),4.03–3.89(m,2H),3.65(s, 3H),2.30–2.19(m,2H),2.06(dd,J=7.4,4.7Hz,2H).其结构式为;a. In a 250mL round bottom flask, add 1.69g (10mmol) of 6-chloroguanine, 80mL N,N-dimethylformamide as solvent, add 1.75g (21mmol) of N-methylpyrrole, stir at 60°C for 24 hours . After the reaction was completed, it was cooled, and the precipitate was washed with 20 mL of acetone, and then purified by filtration to obtain 1.94 g of a white solid with a yield of 76.5%. 1 H NMR (500MHz, DMSO-d6, ppm): δ 13.41 (s, 1H), 8.35 (s, 1H), 7.12 (s, 2H), 4.67–4.48 (m, 2H), 4.03–3.89 (m , 2H), 3.65(s, 3H), 2.30–2.19(m, 2H), 2.06(dd, J=7.4, 4.7Hz, 2H). Its structural formula is;

Figure BDA0002064516160000131
Figure BDA0002064516160000131

b.在50mL圆底烧瓶中加入4-溴-1,8-萘酐277.0mg(1.0mmol),牛磺酸125.1mg(1.0mmol), 20mL EtOH作溶剂,78℃回流搅拌6小时。反应完成后,抽滤得到粗产物,然后经柱层析分离, 以二氯甲烷:甲醇=60:1作为洗脱剂,柱层析分离纯化得褐色固体Ⅰba;279.6mg,产率为79%。1H NMR(500MHz,D2O,ppm):δ7.83(d,J=7.2Hz,2H),7.59(d,J=7.9Hz,1H),7.35(t, J=7.9Hz,1H),7.26(d,J=7.9Hz,1H),4.06(t,J=5.6Hz,2H),3.15(t,J=5.7Hz,2H).其结构式为;b. In a 50mL round-bottomed flask, 277.0mg (1.0mmol) of 4-bromo-1,8-naphthalene anhydride, 125.1mg (1.0mmol) of taurine, and 20mL of EtOH were added as solvent, and the mixture was stirred at 78°C under reflux for 6 hours. After the reaction was completed, the crude product was obtained by suction filtration, and then separated by column chromatography. Using dichloromethane: methanol = 60: 1 as the eluent, column chromatography was used to separate and purify the brown solid Iba; 279.6 mg, the yield was 79% . 1 H NMR (500 MHz, D 2 O, ppm): δ 7.83 (d, J=7.2 Hz, 2H), 7.59 (d, J=7.9 Hz, 1H), 7.35 (t, J=7.9 Hz, 1H) ,7.26(d,J=7.9Hz,1H),4.06(t,J=5.6Hz,2H),3.15(t,J=5.7Hz,2H). Its structural formula is;

Figure BDA0002064516160000141
Figure BDA0002064516160000141

c.在50mL圆底烧瓶中加入中间体Ⅰba 355.0mg(1.0mmol),氨甲基苄醇137.0mg(1.0mmol), 20mL N,N-二甲基甲酰胺作溶剂,加入碳酸钾138.0mg(1mmol),回流搅拌8小时。反应完成后,调节pH为4-5,将溶剂减压蒸馏,剩余物经柱层析分离,以二氯甲烷:甲醇=40:1作为淋洗液,柱层析分离纯化得褐色固体Ⅰca 264.0mg,产率为60%。1H NMR(500MHz,DMSO-d6,ppm):δ8.57(d,J=7.2Hz,2H),8.33(d,J=7.9Hz,1H),8.20(d,J=7.9Hz,1H),7.98 (t,J=7.9Hz,1H),7.35-7.36(m,1H),7.33(d,J=7.9Hz,2H),7.25(d,J=8.0Hz,2H),5.22(s, 2H),5.14(t,J=5.6Hz,1H),4.44(d,J=5.6Hz,2H).3.15(t,J=5.6Hz,2H),4.06(t,J=5.6Hz, 2H).其结构式为;c. In a 50mL round-bottomed flask, add 355.0mg (1.0mmol) of Intermediate Iba, 137.0mg (1.0mmol) of aminomethyl benzyl alcohol, 20mL of N,N-dimethylformamide as a solvent, add 138.0mg of potassium carbonate ( 1 mmol), and stirred at reflux for 8 hours. After the completion of the reaction, the pH was adjusted to 4-5, the solvent was distilled under reduced pressure, the residue was separated by column chromatography, and dichloromethane:methanol=40:1 was used as the eluent, and the column chromatography was separated and purified to obtain a brown solid Ica 264.0 mg, the yield was 60%. 1 H NMR (500MHz, DMSO-d6, ppm): δ 8.57 (d, J=7.2Hz, 2H), 8.33 (d, J=7.9Hz, 1H), 8.20 (d, J=7.9Hz, 1H) ,7.98(t,J=7.9Hz,1H),7.35-7.36(m,1H),7.33(d,J=7.9Hz,2H),7.25(d,J=8.0Hz,2H),5.22(s, 2H), 5.14(t, J=5.6Hz, 1H), 4.44(d, J=5.6Hz, 2H). 3.15(t, J=5.6Hz, 2H), 4.06(t, J=5.6Hz, 2H) . Its structural formula is;

Figure BDA0002064516160000142
Figure BDA0002064516160000142

d.在50mL中加入中间体Ⅰca 440.0mg(1.0mmol),中间体M 635.1mg(2.5mmol),10mL干燥的N,N-二甲基甲酰胺,加入t-BuOK 684.80mg(5mmol),在N2保护下常温搅拌3小时。TLC 点板跟踪,反应完成后,将溶剂减压蒸馏,调节pH为4-5,剩余物经柱层析分离,以二氯甲烷:甲醇=20:1作为淋洗液,柱层析分离纯化得深棕色固体303.7mg,产率为53%。1HNMR (500MHz,DMSO-d6,ppm):δ12.41(s,1H),8.57(d,J=7.2Hz,2H),8.44(d,J=7.2Hz,1H)8.33 (d,J=7.9Hz,1H),8.20(d,J=7.9Hz,1H),7.98(t,J=7.9Hz,1H),7.35(m,1H),7.33(d,J=7.9 Hz,2H),7.25(d,J=8.0Hz,2H),5.36(s,2H),5.22(s,2H),5.14(t,J=5.6Hz,1H),4.44(d,J=5.6 Hz,2H),4.06(t,J=5.6Hz,2H),3.15(t,J=5.7Hz,2H).其结构式为:d. Add 440.0 mg (1.0 mmol) of Intermediate Ica, 635.1 mg (2.5 mmol) of Intermediate M, 10 mL of dry N,N-dimethylformamide to 50 mL, add 684.80 mg (5 mmol) of t-BuOK, and Stir at room temperature for 3 hours under N2 protection. TLC spot plate tracking, after the completion of the reaction, the solvent was distilled under reduced pressure to adjust the pH to 4-5, the residue was separated by column chromatography, using dichloromethane: methanol = 20:1 as the eluent, column chromatography separation and purification A dark brown solid, 303.7 mg, was obtained with a yield of 53%. 1 HNMR (500MHz, DMSO-d6, ppm): δ 12.41 (s, 1H), 8.57 (d, J=7.2Hz, 2H), 8.44 (d, J=7.2Hz, 1H) 8.33 (d, J= 7.9Hz, 1H), 8.20 (d, J=7.9Hz, 1H), 7.98 (t, J=7.9Hz, 1H), 7.35 (m, 1H), 7.33 (d, J=7.9 Hz, 2H), 7.25 (d, J=8.0Hz, 2H), 5.36(s, 2H), 5.22(s, 2H), 5.14(t, J=5.6Hz, 1H), 4.44(d, J=5.6 Hz, 2H), 4.06 (t, J=5.6Hz, 2H), 3.15 (t, J=5.7Hz, 2H). Its structural formula is:

Figure BDA0002064516160000151
Figure BDA0002064516160000151

实施例二:苝酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物B1的制备;Example 2: Preparation of Peryleneimide Fluorescently Labeled O 6 -benzylguanine Derivative B 1 ;

a.在50ml圆底烧瓶中加入四氯苝酐532.0mg(1.0mmol),20mL乙二醇甲醚作溶剂,牛磺酸 125.1mg(1.0mmol),100℃回流搅拌6小时。反应完成后,抽滤得到粗产物,然后经柱层析分离,以二氯甲烷:甲醇=60:1作为淋洗液,柱层析分离纯化得深红色固体化合物Ⅱaa; 477.9mg,产率为75%。1H NMR(500MHz,DMSO-d6,ppm):δ7.92(s,2H),6.28(s,2H),3.64(t,J =5.6Hz,2H),3.33(t,J=5.7Hz,2H).其结构式为:a. Add 532.0 mg (1.0 mmol) of tetrachloroperylene anhydride, 20 mL of ethylene glycol methyl ether as solvent, 125.1 mg (1.0 mmol) of taurine into a 50 ml round-bottomed flask, and stir under reflux at 100°C for 6 hours. After the reaction was completed, the crude product was obtained by suction filtration, and then separated by column chromatography, with dichloromethane: methanol=60:1 as the eluent, and the column chromatography was separated and purified to obtain a dark red solid compound IIaa; 477.9 mg, the yield was 477.9 mg. 75%. 1 H NMR (500MHz, DMSO-d6, ppm): δ 7.92 (s, 2H), 6.28 (s, 2H), 3.64 (t, J = 5.6 Hz, 2H), 3.33 (t, J = 5.7 Hz, 2H). Its structural formula is:

Figure BDA0002064516160000152
Figure BDA0002064516160000152

b.在50mL圆底烧瓶中加入中间体Ⅱaa 637.0mg(1.0mmol),氨甲基苄醇137.0mg(1.0mmol), 20mLDMF作溶剂,回流搅拌8小时。反应完成后,将溶剂减压蒸馏,剩余物经柱层析分离,以二氯甲烷:甲醇=40:1作为淋洗液,柱层析分离纯化得深紫红色固体Ⅱba612.4mg,产率 81%。1H NMR(500MHz,DMSO-d6,ppm):δ7.92(s,2H),7.33(d,J=7.9Hz,2H),7.25(d,J=8.0 Hz,2H),6.28(s,2H),5.22(s,2H),5.14(t,J=5.7Hz,1H),4.44(d,J=5.6Hz,2H),3.64(t,J=5.6 Hz,2H),3.33(t,J=5.6Hz,2H).其结构式为:b. Add 637.0 mg (1.0 mmol) of Intermediate IIaa, 137.0 mg (1.0 mmol) of aminomethylbenzyl alcohol, and 20 mL of DMF as solvent to a 50 mL round-bottomed flask, and stir at reflux for 8 hours. After the reaction was completed, the solvent was distilled under reduced pressure, and the residue was separated by column chromatography. Using dichloromethane: methanol = 40:1 as the eluent, column chromatography was used to separate and purify a dark purple-red solid IIba 612.4 mg, with a yield of 81 %. 1 H NMR (500MHz, DMSO-d6, ppm): δ 7.92 (s, 2H), 7.33 (d, J=7.9 Hz, 2H), 7.25 (d, J=8.0 Hz, 2H), 6.28 (s, 2H), 5.22(s, 2H), 5.14(t, J=5.7Hz, 1H), 4.44(d, J=5.6Hz, 2H), 3.64(t, J=5.6 Hz, 2H), 3.33(t, J=5.6Hz, 2H). Its structural formula is:

Figure BDA0002064516160000161
Figure BDA0002064516160000161

c.在50mL中加入中间体Ⅱba 756.0mg(1.0mmol),对叔丁基酚750mg(5mmol),20mLN,N- 二甲基甲酰胺,加入碳酸钾414.0mg(3mmol),130℃反应6h。TLC点板跟踪,反应完成后,将溶剂减压蒸馏,调节pH为4-5,剩余物经柱层析分离,以二氯甲烷:甲醇=30:1作为淋洗液,柱层析分离纯化得深紫红色固体化合物Ⅱca 1.0302g,产率85%。1H NMR(500MHz,DMSO-d6,ppm):δ7.92(s,2H),7.33(d,J=7.9Hz,2H),7.29(d,J=8.5Hz,8H),7.25(d,J=8.0 Hz,2H),6.74(d,J=8.0Hz,8H),6.28(s,J=8.5Hz,2H),5.22(s,2H),5.14(t,J=5.7Hz,1H),4.44 (d,J=5.6Hz,2H),3.33(t,J=5.7Hz,2H,),3.64(t,J=5.6Hz,2H),1.42(s,36H).其结构式为:c. Add 756.0 mg (1.0 mmol) of Intermediate IIba, 750 mg (5 mmol) of p-tert-butylphenol, 20 mL of N,N-dimethylformamide to 50 mL, add 414.0 mg (3 mmol) of potassium carbonate, and react at 130°C for 6 h. TLC spot plate tracking, after the completion of the reaction, the solvent was distilled under reduced pressure to adjust the pH to 4-5, the residue was separated by column chromatography, using dichloromethane: methanol = 30:1 as the eluent, column chromatography separation and purification The deep purple-red solid compound IIca 1.0302g was obtained, and the yield was 85%. 1 H NMR (500MHz, DMSO-d6, ppm): δ 7.92 (s, 2H), 7.33 (d, J=7.9Hz, 2H), 7.29 (d, J=8.5Hz, 8H), 7.25 (d, J=8.0 Hz, 2H), 6.74(d, J=8.0Hz, 8H), 6.28(s, J=8.5Hz, 2H), 5.22(s, 2H), 5.14(t, J=5.7Hz, 1H) ,4.44(d,J=5.6Hz,2H),3.33(t,J=5.7Hz,2H,),3.64(t,J=5.6Hz,2H),1.42(s,36H). Its structural formula is:

Figure BDA0002064516160000162
Figure BDA0002064516160000162

d.在50mL中加入中间体Ⅱca 1213.5mg(1.0mmol),中间体M 635.1mg(2.5mmol),10mL 干燥的N,N-二甲基甲酰胺,加入t-BuOK 684.80mg(5mmol),在N2保护下常温搅拌3小时。 TLC点板跟踪,反应完成后,将溶剂减压蒸馏,调节pH为4-5,剩余物经柱层析分离,以二氯甲烷:甲醇=20:1作为淋洗液,柱层析分离纯化得深棕色纯产品化合物874.2mg,产率63%。1H NMR(500MHz,DMSO-d6,ppm):δ12.41(s,1H),8.44(d,J=7.2Hz,1H),7.92(s,2H),7.33(d,J=7.9Hz,2H),7.25(d,J=8.0Hz,2H),7.29(d,J=8.5Hz,8H),6.74(d,J=8.0Hz,8H), 6.28(s,2H),5.36(s,2H),5.22(s,2H),4.44(d,J=5.6Hz,2H),3.33(t,J=5.7Hz,2H),3.64(t,J= 5.6Hz,2H),1.42(s,36H)d. Add 1213.5 mg (1.0 mmol) of Intermediate IIca, 635.1 mg (2.5 mmol) of Intermediate M, 10 mL of dry N,N-dimethylformamide to 50 mL, add 684.80 mg (5 mmol) of t-BuOK, Stir at room temperature for 3 hours under N2 protection. TLC spot plate tracking, after the completion of the reaction, the solvent was distilled under reduced pressure to adjust the pH to 4-5, the residue was separated by column chromatography, using dichloromethane: methanol = 20:1 as the eluent, column chromatography separation and purification 874.2 mg of pure dark brown product compound was obtained in a yield of 63%. 1 H NMR (500MHz, DMSO-d6, ppm): δ 12.41 (s, 1H), 8.44 (d, J=7.2Hz, 1H), 7.92 (s, 2H), 7.33 (d, J=7.9Hz, 2H), 7.25(d, J=8.0Hz, 2H), 7.29(d, J=8.5Hz, 8H), 6.74(d, J=8.0Hz, 8H), 6.28(s, 2H), 5.36(s, 2H), 5.22(s, 2H), 4.44(d, J=5.6Hz, 2H), 3.33(t, J=5.7Hz, 2H), 3.64(t, J= 5.6Hz, 2H), 1.42(s, 36H)

Figure BDA0002064516160000171
Figure BDA0002064516160000171

实施例三:萘酰亚胺荧光标记的O6-苄基鸟嘌呤同分子孪生的荧光蛋白质标记物c的方法:Example 3: The method for fluorescently labeling O 6 -benzylguanine homomolecular twinned fluorescent protein label c with naphthalimide:

a.在50mL圆底烧瓶中加入4-溴-1,8-萘酐554.0mg(2.0mmol),氨甲基苄醇274.0mg(2.0 mmol),20mL无水乙醇作溶剂,78℃回流搅拌6小时。反应完成后,抽滤得到粗产物,然后经柱层析分离,以二氯甲烷:甲醇=100:1作为淋洗液,柱层析分离纯化得白色固体为纯产品化合物Ⅲa 636.6mg,产率82%。1H NMR(400MHz,DMSO-d6,ppm):δ8.57(d,J=7.2Hz,2H), 8.33(d,J=7.9Hz,1H),8.20(d,J=7.9Hz,1H),7.98(t,J=7.9Hz,1H),7.33(d,J=7.9Hz,2H), 7.25(d,J=8.0Hz,2H),5.22(s,2H),5.14(t,J=5.7Hz,1H),4.44(d,J=5.6Hz,2H).其结构式为:a. In a 50mL round-bottomed flask, add 554.0mg (2.0mmol) of 4-bromo-1,8-naphthalene anhydride, 274.0mg (2.0 mmol) of aminomethyl benzyl alcohol, 20mL of absolute ethanol as solvent, and reflux at 78°C with stirring for 6 Hour. After the reaction was completed, the crude product was obtained by suction filtration, and then separated by column chromatography. With dichloromethane: methanol=100:1 as the eluent, the white solid was separated and purified by column chromatography to obtain a pure product compound IIIa 636.6 mg. The yield was 636.6 mg. 82%. 1 H NMR (400MHz, DMSO-d6, ppm): δ 8.57 (d, J=7.2Hz, 2H), 8.33 (d, J=7.9Hz, 1H), 8.20 (d, J=7.9Hz, 1H) ,7.98(t,J=7.9Hz,1H),7.33(d,J=7.9Hz,2H),7.25(d,J=8.0Hz,2H),5.22(s,2H),5.14(t,J= 5.7Hz, 1H), 4.44 (d, J=5.6Hz, 2H). Its structural formula is:

Figure BDA0002064516160000172
Figure BDA0002064516160000172

在50mL圆底烧瓶中加入中间体Ⅲa 395.0mg(1.0mmol),氨甲基苄醇137.0mg(1.0mmol), 20mL N,N-二甲基甲酰胺作溶剂,加入碳酸钾138.0mg(1mmol),回流搅拌8小时。反应完成后,调节pH为4-5,将溶剂减压蒸馏,剩余物经柱层析分离,以二氯甲烷:甲醇=40:1作为淋洗液,柱层析分离纯化得浅褐色固体Ⅲb 327.6mg,产率70%。1H NMR(400MHz,DMSO-d6,ppm):δ8.57(d,J=7.2Hz,1H),8.53(d,J=8.5Hz,1H),8.33(d,J=7.9Hz,1H),8.20 (d,J=7.9Hz,1H),7.98(t,J=7.9Hz,1H),7.35-7.36(m,1H),7.33(d,J=7.9Hz,4H),7.25(d,J= 8.0Hz,4H),5.22(s,4H),5.14(t,J=5.7Hz,2H),4.44(d,J=5.6Hz,4H).其结构式为:In a 50mL round-bottomed flask, 395.0mg (1.0mmol) of Intermediate IIIa, 137.0mg (1.0mmol) of aminomethyl benzyl alcohol, 20mL of N,N-dimethylformamide were added as a solvent, and 138.0mg (1mmol) of potassium carbonate was added. , stirring at reflux for 8 hours. After the completion of the reaction, the pH was adjusted to 4-5, the solvent was distilled under reduced pressure, and the residue was separated by column chromatography. Using dichloromethane:methanol=40:1 as the eluent, column chromatography was used to separate and purify the light brown solid IIIb. 327.6 mg, 70% yield. 1 H NMR (400MHz, DMSO-d6, ppm): δ 8.57 (d, J=7.2Hz, 1H), 8.53 (d, J=8.5Hz, 1H), 8.33 (d, J=7.9Hz, 1H) ,8.20(d,J=7.9Hz,1H),7.98(t,J=7.9Hz,1H),7.35-7.36(m,1H),7.33(d,J=7.9Hz,4H),7.25(d, J=8.0Hz, 4H), 5.22(s, 4H), 5.14(t, J=5.7Hz, 2H), 4.44(d, J=5.6Hz, 4H). Its structural formula is:

Figure BDA0002064516160000181
Figure BDA0002064516160000181

在50mL中加入中间体Ⅰca 440.0mg(1.0mmol),中间体M 1016mg(4mmol),10mL干燥的DMF,加入t-BuOK1088mg(8mmol),在N2保护下常温搅拌3小时。TLC点板跟踪,反应完成后,将溶剂减压蒸馏,调节pH为4-5,剩余物经柱层析分离,以二氯甲烷:甲醇=20: 1作为淋洗液,柱层析分离纯化得深棕色纯产品化合物574.4mg,产率80%。1H NMR(500 MHz,DMSO-d6,ppm):δ12.41(s,2H),8.57(d,J=7.2Hz,2H),8.44(d,J=7.2Hz,2H)8.33(d,J =7.9Hz,1H),8.20(d,J=7.9Hz,1H),7.98(t,J=7.9Hz,1H),7.35-7.36(m,1H),7.33(d,J=7.9 Hz,4H),7.25(d,J=8.0Hz,4H),5.36(s,4H),5.22(s,4H),4.44(d,J=5.6Hz,4H).其结构式为:Add 440.0 mg (1.0 mmol) of intermediate Ica, 1016 mg (4 mmol) of intermediate M, 10 mL of dry DMF to 50 mL, add 1088 mg (8 mmol) of t-BuOK, and stir at room temperature for 3 hours under the protection of N 2 . TLC spot plate tracking, after the completion of the reaction, the solvent was distilled under reduced pressure to adjust the pH to 4-5, the residue was separated by column chromatography, using dichloromethane: methanol = 20: 1 as eluent, column chromatography separation and purification 574.4 mg of pure dark brown product compound was obtained in 80% yield. 1 H NMR (500 MHz, DMSO-d6, ppm): δ 12.41 (s, 2H), 8.57 (d, J=7.2 Hz, 2H), 8.44 (d, J=7.2 Hz, 2H) 8.33 (d, J=7.9Hz, 1H), 8.20(d, J=7.9Hz, 1H), 7.98(t, J=7.9Hz, 1H), 7.35-7.36(m, 1H), 7.33(d, J=7.9 Hz, 4H), 7.25(d, J=8.0Hz, 4H), 5.36(s, 4H), 5.22(s, 4H), 4.44(d, J=5.6Hz, 4H). Its structural formula is:

Figure BDA0002064516160000182
Figure BDA0002064516160000182

实施例四:苝酰亚胺荧光标记的O6-苄基鸟嘌呤同分子荧光孪生标记物d的制备:Example 4: Preparation of peryleneimide fluorescently labeled O 6 -benzylguanine homomolecular fluorescent twin label d:

a.在50mL圆底烧瓶中加入四氯苝酐532.0mg(1.0mmol),20mL无水乙醇作溶剂,氨甲基苄醇274.0mg(2.0mmol),100℃回流搅拌6小时。反应完成后,抽滤得到粗产物,然后经柱层析分离,以石油醚:乙酸乙酯=1:1作为淋洗液,柱层析分离纯化得深红色固体化合物Ⅳa 477.9mg,产率75%。1H NMR(500MHz,DMSO-d6,ppm):δ7.92(s,J=8.5Hz,4H),7.33(d,J= 7.9Hz,4H),7.25(d,J=8.0Hz,4H),5.22(s,4H),5.14(t,J=5.7Hz,2H),4.44(d,J=5.6Hz,4H). 其结构式为:a. In a 50 mL round-bottomed flask, add 532.0 mg (1.0 mmol) of tetrachloroperylene anhydride, 20 mL of absolute ethanol as solvent, and 274.0 mg (2.0 mmol) of aminomethylbenzyl alcohol, and stir at 100° C. for 6 hours under reflux. After the reaction was completed, the crude product was obtained by suction filtration, and then separated by column chromatography, with petroleum ether: ethyl acetate=1:1 as the eluent, and the column chromatography was separated and purified to obtain 477.9 mg of dark red solid compound IVa, with a yield of 75 %. 1 H NMR (500MHz, DMSO-d6, ppm): δ 7.92 (s, J=8.5Hz, 4H), 7.33 (d, J=7.9Hz, 4H), 7.25 (d, J=8.0Hz, 4H) ,5.22(s,4H),5.14(t,J=5.7Hz,2H),4.44(d,J=5.6Hz,4H). Its structural formula is:

Figure BDA0002064516160000191
Figure BDA0002064516160000191

在25mL圆底烧瓶中加入中间体Ⅳa 230.4mg(0.3mmol),对叔丁基酚225mg(1.5mmol), 10mL N,N-二甲基甲酰胺,加入碳酸钾124.2mg(0.9mmol),130℃反应6h。TLC点板跟踪,反应完成后,将溶剂减压蒸馏,调节pH为4-5,剩余物经柱层析分离,以二氯甲烷:甲醇=30: 1作为淋洗液,柱层析分离纯化得深紫红色固体Ⅱca 293.8mg,产率80%。1H NMR(500MHz, DMSO-d6,ppm):δ7.92(s,4H),7.29(d,J=8.5Hz,8H),7.33(d,J=7.9Hz,4H),6.74(d,J=8.0 Hz,8H),7.25(d,J=8.0Hz,4H),5.22(s,4H),5.14(t,J=5.7Hz,2H),4.44(d,J=5.6Hz,4H), 1.42(s,36H).其结构式为:In a 25mL round-bottomed flask, add 230.4mg (0.3mmol) of Intermediate IVa, 225mg (1.5mmol) of p-tert-butylphenol, 10mL of N,N-dimethylformamide, add 124.2mg (0.9mmol) of potassium carbonate, 130 ℃ reaction 6h. TLC spot plate tracking, after the completion of the reaction, the solvent was distilled under reduced pressure, the pH was adjusted to 4-5, the residue was separated by column chromatography, and dichloromethane: methanol = 30: 1 was used as the eluent, and the column chromatography was separated and purified. 293.8 mg of dark purple-red solid IIca was obtained with a yield of 80%. 1 H NMR (500MHz, DMSO-d6, ppm): δ 7.92(s, 4H), 7.29(d, J=8.5Hz, 8H), 7.33(d, J=7.9Hz, 4H), 6.74(d, J=8.0 Hz, 8H), 7.25(d, J=8.0Hz, 4H), 5.22(s, 4H), 5.14(t, J=5.7Hz, 2H), 4.44(d, J=5.6Hz, 4H) , 1.42(s,36H). Its structural formula is:

Figure BDA0002064516160000192
Figure BDA0002064516160000192

在50mL中加入中间体Ⅳb244.8mg(0.2mmol),中间体M 203.2mg(0.8mmol),10mL干燥的N,N-二甲基甲酰胺,加入t-BuOK 217.6mg(1.6mmol),在N2保护下常温搅拌3小时。TLC点板跟踪,反应完成后,将溶剂减压蒸馏,剩余物经柱层析分离,以二氯甲烷:甲醇=20:1作为淋洗液,柱层析分离纯化得深紫色纯产品化合物232.2mg,产率78%。1H NMR(500MHz,DMSO-d6,ppm):δ12.41(s,2H),8.44(d,J=7.2Hz,2H),7.92(s,4H),7.29(d,J=8.5Hz,8H),7.33(d,J=7.9Hz,4H),6.74(d,J=8.0Hz,8H),7.25(d,J=8.0Hz,4H),5.36(s,4H),5.22(s,4H), 4.44(d,J=5.6Hz,4H),1.42(s,36H).其结构式为:In 50mL, add Intermediate IVb 244.8mg (0.2mmol), Intermediate M 203.2mg (0.8mmol), 10mL dry N,N-dimethylformamide, add t-BuOK 217.6mg (1.6mmol), in N 2 Stir at room temperature for 3 hours under the protection. TLC spot plate tracking, after the completion of the reaction, the solvent was distilled under reduced pressure, the residue was separated by column chromatography, using dichloromethane: methanol = 20:1 as the eluent, column chromatography separation and purification to obtain a dark purple pure product compound 232.2 mg, 78% yield. 1 H NMR (500MHz, DMSO-d6, ppm): δ 12.41 (s, 2H), 8.44 (d, J=7.2Hz, 2H), 7.92 (s, 4H), 7.29 (d, J=8.5Hz, 8H), 7.33(d, J=7.9Hz, 4H), 6.74(d, J=8.0Hz, 8H), 7.25(d, J=8.0Hz, 4H), 5.36(s, 4H), 5.22(s, 4H), 4.44(d, J=5.6Hz, 4H), 1.42(s, 36H). Its structural formula is:

Figure BDA0002064516160000201
Figure BDA0002064516160000201

Claims (3)

1.一种萘酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物,其特征在于,该衍生物的结构通式为下列之一:1. a O 6 -benzylguanine derivative of naphthalimide fluorescent labeling is characterized in that, the general structural formula of this derivative is one of the following: a.a.
Figure FDA0003532136910000011
Figure FDA0003532136910000011
c.c.
Figure FDA0003532136910000012
Figure FDA0003532136910000012
其中R为烷基。wherein R is an alkyl group.
2.一种根据权利要求1所述萘酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物的制备方法,其特征在于,该方法的具体步骤为:2. a kind of preparation method of the O 6 -benzylguanine derivative of naphthalimide fluorescent labeling according to claim 1, is characterized in that, the concrete steps of this method are: a.将6-氯鸟嘌呤和N-甲基吡咯烷按1:1.5-1:2.1的摩尔比溶于N,N-二甲基甲酰胺中,60℃-100℃,反应24h-48h,反应结束抽滤,用丙酮洗涤滤渣,抽滤得到化合物M,其结构式为:a. Dissolve 6-chloroguanine and N-methylpyrrolidine in N,N-dimethylformamide in a molar ratio of 1:1.5-1:2.1, at 60℃-100℃, react for 24h-48h, The reaction finishes suction filtration, and the filter residue is washed with acetone, and suction filtration obtains compound M, and its structural formula is:
Figure FDA0003532136910000013
Figure FDA0003532136910000013
b.将4-溴-1,8-萘酐和有机磺酸盐按1:1.2-1:1.5的摩尔比溶于无水乙醇中,回流条件下反应6h-12h,冷却,滤出固体粗产物,再经分离提纯得到化合物Ⅰb,其结构式为:b. Dissolve 4-bromo-1,8-naphthalene anhydride and organic sulfonate in absolute ethanol at a molar ratio of 1:1.2-1:1.5, react under reflux conditions for 6h-12h, cool, and filter out the solid crude The product is separated and purified to obtain compound Ib, and its structural formula is:
Figure FDA0003532136910000014
所述的有机磺酸盐的结构式为:NH2RSO3H;
Figure FDA0003532136910000014
The structural formula of the organic sulfonate is: NH 2 RSO 3 H;
c.将步骤b所得中间产物化合物Ⅰb、氨甲基苄醇和碳酸钾按1:1:1.2-1;1.5:2.0的摩尔比溶于N,N-二甲基甲酰胺,回流反应6~8h,得到深褐色反应液,调节pH为4~5,除去大部分溶剂,得到糊状物质,抽滤,得到粗产物;再经分离提纯得化合物Ⅰc,其结构式为:c. Dissolve the intermediate product Compound 1b, aminomethylbenzyl alcohol and potassium carbonate obtained in step b in N,N-dimethylformamide in a molar ratio of 1:1:1.2-1; 1.5:2.0, and react under reflux for 6-8h , obtain a dark brown reaction solution, adjust the pH to 4-5, remove most of the solvent to obtain a paste-like substance, suction filtration to obtain a crude product; and then separate and purify to obtain compound Ic, whose structural formula is:
Figure FDA0003532136910000021
Figure FDA0003532136910000021
d.将步骤c所得中间产物化合物Ⅰc和步骤a中所得化合物M和t-BuOK按1:2:5-1:3:5的摩尔比溶于N,N-二甲基甲酰胺中,惰性气氛保护下,反应3h-8h,经分离提纯得到萘酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物a,其结构式为:d. The intermediate product Compound Ic obtained in step c and compound M and t-BuOK obtained in step a are dissolved in N,N-dimethylformamide in a molar ratio of 1:2:5-1:3:5, inert Under the protection of atmosphere, the reaction is carried out for 3h-8h, and the naphthalimide fluorescently labeled O 6 -benzylguanine derivative a is obtained by separation and purification, and its structural formula is:
Figure FDA0003532136910000022
Figure FDA0003532136910000022
3.一种根据权利要求1所述萘酰亚胺荧光标记的O6-苄基鸟嘌呤衍生物的制备方法,其特征在于,该方法的具体步骤为:3. a preparation method of the O 6 -benzylguanine derivative of naphthalimide fluorescent labeling according to claim 1, is characterized in that, the concrete steps of this method are: e.将4-溴-1,8-萘酐和氨甲基苄醇按1:1.2-1:1.5的摩尔比溶于无水乙醇中,回流条件下反应6h-12h,冷却,滤出固体粗产物,再经分离提纯得到化合物Ⅲa,其结构式为:e. Dissolve 4-bromo-1,8-naphthalene anhydride and aminomethylbenzyl alcohol in absolute ethanol at a molar ratio of 1:1.2-1:1.5, react under reflux conditions for 6h-12h, cool, and filter out the solid The crude product is separated and purified to obtain compound IIIa, whose structural formula is:
Figure FDA0003532136910000023
Figure FDA0003532136910000023
f.将步骤e所得中间产物化合物Ⅲa、氨甲基苄醇和碳酸钾按1:1:1.2-1;1.5:2.0的摩尔比溶于N,N-二甲基甲酰胺,回流反应6~8h,得到深褐色反应液,调节pH为4~5,除去大部分溶剂,得到糊状物质,抽滤,得到粗产物;再经分离提纯得化合物Ⅲb,其结构式为:f. The intermediate product compound IIIa, aminomethylbenzyl alcohol and potassium carbonate obtained in step e were dissolved in N,N-dimethylformamide in a molar ratio of 1:1:1.2-1; 1.5:2.0, and the reaction was refluxed for 6-8h , obtain a dark brown reaction solution, adjust the pH to 4-5, remove most of the solvent to obtain a paste-like substance, suction filtration to obtain a crude product; and then separate and purify to obtain compound IIIb, whose structural formula is:
Figure FDA0003532136910000031
Figure FDA0003532136910000031
g.将步骤f所得产物化合物Ⅲb、化合物M、t-BuOK按1:2:5-1:3:5的摩尔比溶于N,N-二甲基甲酰胺中,所述化合物M的化学式为:
Figure FDA0003532136910000032
惰性气氛保护下,反应3h-8h,分离得到萘酰亚胺荧光标记的O6-苄基鸟嘌呤同分子孪生的荧光蛋白质标记物c,其结构式为:
g. Dissolve the product compound IIIb, compound M, t-BuOK obtained in step f in N,N-dimethylformamide at a molar ratio of 1:2:5-1:3:5. The chemical formula of the compound M is for:
Figure FDA0003532136910000032
Under the protection of an inert atmosphere, the reaction is carried out for 3h-8h, and the fluorescent protein marker c of the naphthalimide fluorescently labeled O 6 -benzylguanine homomolecular twin is obtained, and its structural formula is:
Figure FDA0003532136910000033
Figure FDA0003532136910000033
CN201910416208.4A 2019-05-20 2019-05-20 Fluorescent-labeled O of naphthalimide or perylene bisimide6-benzylguanine derivatives and process for the preparation thereof Active CN110143975B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910416208.4A CN110143975B (en) 2019-05-20 2019-05-20 Fluorescent-labeled O of naphthalimide or perylene bisimide6-benzylguanine derivatives and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910416208.4A CN110143975B (en) 2019-05-20 2019-05-20 Fluorescent-labeled O of naphthalimide or perylene bisimide6-benzylguanine derivatives and process for the preparation thereof

Publications (2)

Publication Number Publication Date
CN110143975A CN110143975A (en) 2019-08-20
CN110143975B true CN110143975B (en) 2022-06-10

Family

ID=67591805

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910416208.4A Active CN110143975B (en) 2019-05-20 2019-05-20 Fluorescent-labeled O of naphthalimide or perylene bisimide6-benzylguanine derivatives and process for the preparation thereof

Country Status (1)

Country Link
CN (1) CN110143975B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121006632A (en) * 2025-08-26 2025-11-25 广东威豹实业有限公司 A fluorescent polyester fiber material, its preparation method, and its application in bags.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413309B1 (en) * 1999-01-26 2002-07-02 Clariant Gmbh Pigment preparations comprising two or more perylene compounds
US20110165691A1 (en) * 2008-07-25 2011-07-07 Basf Se Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions
CN103497154A (en) * 2013-08-12 2014-01-08 北京化工大学 Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells
CN104478876A (en) * 2014-11-25 2015-04-01 辽宁鸿港化工有限公司 N,N'-dimethyl-3,4,9,10-perylenetetracarboxylic diimide derivative and application thereof
CN105837576A (en) * 2015-01-14 2016-08-10 湖北生物医药产业技术研究院有限公司 BTK inhibitors
CN106632412A (en) * 2016-12-27 2017-05-10 武汉工程大学 Perylene diimide compound, as well as preparation method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413309B1 (en) * 1999-01-26 2002-07-02 Clariant Gmbh Pigment preparations comprising two or more perylene compounds
US20110165691A1 (en) * 2008-07-25 2011-07-07 Basf Se Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions
CN103497154A (en) * 2013-08-12 2014-01-08 北京化工大学 Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells
CN104478876A (en) * 2014-11-25 2015-04-01 辽宁鸿港化工有限公司 N,N'-dimethyl-3,4,9,10-perylenetetracarboxylic diimide derivative and application thereof
CN105837576A (en) * 2015-01-14 2016-08-10 湖北生物医药产业技术研究院有限公司 BTK inhibitors
CN106632412A (en) * 2016-12-27 2017-05-10 武汉工程大学 Perylene diimide compound, as well as preparation method and application thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"Covalent and Selective Immobilization of Fusion Proteins"及其Supporting Information;Maik Kindermann等,;《J. AM. CHEM. SOC.》;20030610;第125卷;第7810-7811页及其Supporting Information第S1-S11页 *
"The Synthesis and Fluorescence of Novel N-Substituted-1,8-naphthylimides",;Dongwu Yuan等,;《J. Heterocyclic Chem.》;20080430;第45卷;第397-404页 *
"苝酰亚胺类水溶性荧光化合物的合成";闫轲等,;《精细与专用化学品》;20041006;第12卷(第19期);第18-19页 *
"萘酰亚胺类染料荧光构效关系研究及生物应用";乔庆龙,;《中国博士学位论文全文数据库 工程科技I辑》;20180915(第09期);第B014-95页 *
乔庆龙,."萘酰亚胺类染料荧光构效关系研究及生物应用".《中国博士学位论文全文数据库 工程科技I辑》.2018,(第09期), *

Also Published As

Publication number Publication date
CN110143975A (en) 2019-08-20

Similar Documents

Publication Publication Date Title
CN109574880B (en) Fluorescent probe and preparation method and application thereof
CN110498799B (en) Fluorescent probe and preparation method and application thereof
CN108069967B (en) Fluorescent probe for intracellular protein labeling and synthetic method and application thereof
CN102061103A (en) Type I boron fluoride complex dipyrromethene dye, and preparation method and application thereof
CN106867515A (en) A kind of fluorescence probe and its synthetic method and application for protein labeling and detection
CN113214672A (en) Amide substituted azaindole-pentamethine cyanine dye, its synthesis method and application
CN107098923A (en) One class feux rouges targets fluorescent dye and preparation method thereof and purposes near infrared emission lysosome
CN111978248A (en) Multi-site modifiable aggregation-induced emission quinoline nitrile derivative, and preparation method and application thereof
Song et al. Development and applications of a near-infrared dye–benzylguanine conjugate to specifically label SNAP-tagged proteins
CN1307263C (en) Fluorescent dyes, methods and kits for saturating labeled proteins
CN108504130A (en) A kind of colored cyanine fluorochrome and its synthetic method
CN110229120A (en) A kind of long wavelength's luminescent dye molecule and preparation method thereof
CN110143975B (en) Fluorescent-labeled O of naphthalimide or perylene bisimide6-benzylguanine derivatives and process for the preparation thereof
JP5319130B2 (en) Keiko solvatochromic dye and method of use thereof
CN112010838A (en) Naphthalimide-indole derivative-based intracellular reticulum fluorescent probe and application thereof
CN114702447A (en) Naphthalimide derivative and preparation method and application thereof
WO2023092715A1 (en) Alanine aggregation-induced emission fluorescent probe, and synthesis method therefor and use thereof
CN111333646B (en) High-brightness high-stability wash-free SNAP-tag probe and preparation method and application thereof
CN119798246A (en) Fluorescent probe targeting SHP2, preparation method and application thereof
WO2013152687A1 (en) Preparation method of near-infrared fluorescent dye and application thereof
CN114874639B (en) Novel hemicyanine near infrared fluorescent dye, and synthesis method and application thereof
CN111253309A (en) A kind of acridone type fluorescent amine compound labeling reagent and its synthesis method and application
CN110256339A (en) Organic fluorescent dye molecule and preparation method thereof
WO2019168164A1 (en) Molecule for protein and/or peptide design
CN111333618A (en) 488nm excited wash-free SNAP-tag probe and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant